CiceroDx, Inc. is a diagnostics company dedicated to the advancement of clinical assays for understudied diseases.
Endometriosis is a major focus of CiceroDx, now offering for the first time a global test called ReceptivaDx for all stages of endometriosis. This disease affects over 176 million women and takes 11 years on average to diagnose. Many women spend years dealing with pain, infertility and bowel or bladder symptoms without knowing that endometriosis is the cause.
http://cicerodx.com/
http://www.receptivadx.com/
Company Details
- Employees
- 7
- Founded
- -
- Address
- 2538 Anthem Village Drive,
- Industry
- Hospitals And Health Care
- NAICS
-
Health Care and Social AssistanceSocial Assistance
- Website
- http://cicerodx.com/
- Keywords
- Denver.
- HQ
- Henderson, NV
Cicerodiagnostics, Inc. Questions
Cicerodiagnostics, Inc.'s website is http://cicerodx.com/
Cicerodiagnostics, Inc.'s LinkedIn profile is https://www.linkedin.com/company/cicerodiagnostics
Cicerodiagnostics, Inc. has
7 employees.
View email and phone details for 7
employees at Cicerodiagnostics, Inc..
Cicerodiagnostics, Inc.'s industry is
Hospitals and Health Care
Cicerodiagnostics, Inc.'s top competitors are
Genaxxon Bioscience Gmbh,
Nextgen Lifelabs Llc,
Cryobio Donor Sperm Bank,
Brownstone Health,
Memphasys Reproductive Biotechnology,
Sera Prognostics,
Embryomic,
Southwest Embryology Summit,
Spectrum Fertility Group,
Covita Health Partners.
Cicerodiagnostics, Inc.'s categories are Hospitals and Health Care
Cicerodiagnostics, Inc.'s founding year is 2015
